SATB2 and Alzheimer disease: In contrast, on week 4, reverse transcription-quantitative PCR (RT-qPCR) revealed that cerebral organoids from AD patients exhibited higher mRNA levels of mature neuronal markers including MAP2, CTIP2, and SATB2, but not GFAP, an astrocyte marker (Supplementary Fig. 3A–D).